Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Temporary logo for l'institut Agro / Agrocampus Ouest

Internet de l'unité STLO Science et Technologie du Lait et de l'Oeuf

STLO Research Unit

Magic SlpB protein confers probiotic superpowers to a cheese bug

Propionibacteria
Propionibacterium freudenreichii is a beneficial bacterium, a good bug, with a long history of safe use. It has been used to ripen cheeses and to give them aroma, since ancient times. It also recently revealed probiotic potential, including the ability to mitigate inflammation. Elucidating this anti-inflammatory effect may open new avenues for the development of functional foods and supplements.

Propionibacterium freudenreichii (Pf) is a beneficial bacterium, a good bug, with a long history of safe use. It has been used since ancient times to ripen cheeses such as emmental and to give them aroma. It also recently revealed probiotic potential, including the ability to mitigate inflammation. Elucidating this anti-inflammatory effect may open new avenues for the development of functional foods and supplements.

Propionibacterium freudenreichii was recently recognized as a probiotic bacterium able to mitigate intestinal inflammation via Th17 lymphocytes regulation. Some strains, including Pf CIRM-BIA129 possess peculiar surface extractible proteins, of the surface-layer type, called Slps. We investigated here the specific role of one of these surface extractible proteins, called SlpB, in this beneficial probiotic effect of the strain Pf CIRM-BIA129.

We found that:

  • The protein SlpB mediates adhesion of Propionibacterium freudenreichii CIRM-BIA129 to human intestinal epithelial cells
  • SlpB of Propionibacterium freudenreichii is able to modulate the immune response of human leucocytes (PBMCs)
  • SlpB is required for Propionibacterium freudenreichii to mitigate inflammation in vivo
MR_24-SlpB-Gwen-visuel-scientific-mixte

Left: The normal structure of the intestinal epithelium (A) is destroyed during inflammatory mucositis (B). This destruction is avoided by consumption of Propionibacterium freudenreichii CIRM-BIA129, that possess the surface protein SlpB (C), but not by its mutant inactivated in slpB gene and thus enable to produce the SlpB protein (D).

Right: Antibodies directed against the surface protein SlpB (anti-SlpB) inhibit adhesion of Propionibacterium freudenreichii CIRM-BIA129 to cultures of human intestinal epithelial cells. So does the mutational inactivation of the slpB gene.

 
 The elucidation of the natural molecules, produced by probiotic bacteria, which do trigger an immunomodulatory response, mitigating inflammation, opens new perspectives for the development of active ingredients, both for the functional food development and for the pharmaceutical innovation.

FiletGris

 Collaborations

Read more

Deutsch, S.-M., Mariadassou, M., Nicolas, P., Parayre, S., Le Guellec, R., Chuat, V., et al. (2017). Identification of proteins involved in the anti-inflammatory properties of Propionibacterium freudenreichii by means of a multi-strain study. Sci Rep 7, 46409. DOI:10.1038/srep46409.

do Carmo, F. L. R., Rabah, H., Cordeiro, B. F., da Silva, S. H., Pessoa, R. M., Fernandes, S. O. A., et al. (2019). Probiotic  Propionibacterium freudenreichii requires SlpB protein to mitigate mucositis induced by chemotherapy. Oncotarget 10, 7198–7219. doi:10.18632/oncotarget.27319.

do Carmo, F. L. R., Rabah, H., Huang, S., Gaucher, F., Deplanche, M., Dutertre, S., et al. (2017). Propionibacterium freudenreichii Surface Protein SlpB Is Involved in Adhesion to Intestinal HT-29 Cells. Front Microbiol 8, 1033. doi:10.3389/fmicb.2017.01033.

do Carmo, F. L. R., Silva, W. M., Tavares, G. C., Ibraim, I. C., Cordeiro, B. F., Oliveira, E. R., et al. (2018). Mutation of the Surface Layer Protein SlpB Has Pleiotropic Effects in the Probiotic Propionibacterium freudenreichii CIRM-BIA 129. Front. Microbiol. 9, 1807. doi:10.3389/fmicb.2018.01807.

Rodovalho, V. de R., Luz, B. S. R. da, Rabah, H., Carmo, F. L. R. D., Folador, E. L., Nicolas, A., et al. (2020). Extracellular vesicles produced by the probiotic Propionibacterium freudenreichii CIRM-BIA129 mitigate inflammation by modulating the NF-κB pathway. Frontiers in Microbiology 11. doi:10.3389/fmicb.2020.01544.

Contacts

Gwénaël Jan • gwenael.jan@inrae.fr

>>> To Research Team
 
>>> To All MAIN RESULTS